This study suggests a functional link between GLP-1 and ANP in improving lung function and reducing inflammation in COPD, highlighting their therapeutic potential [55]
Treatment with GLP-1 receptor agonists
This is a significant step up in commitment, complexity, and cost, but it also represents a significant step up in effectiveness
Holmes V.A., Draffin C.R., Patterson C.C., et al
Retatrutide also lowered fasting and postprandial glucose, reduced appetite, and improved lipid profiles, including reductions in low-density lipoprotein (LDL) cholesterol and triglycerides
14.3 Dose Adjustments and Monitoring Needs Dose titration should proceed cautiously